Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Government Emphasis On Preventative Care Needed To Curb Healthcare Costs in Asia

This article was originally published in PharmAsia News

Executive Summary

SHANGHAI - Creating incentives for people to lead a healthy lifestyle is one key to expanding access to healthcare in Asia, especially as the population ages and takes up more of limited national budgets, according to a recent report from global consulting firm Frost & Sullivan

You may also be interested in...



Riding High And Scaling Up, Chindex Readies Business Model Rollout In China

American hospital operator and medical device distributor Chindex is riding strong midterm growth momentum built on its strong branding in China and will likely benefit hugely from China's healthcare reforms and growing middle class.

Philippines To Set National R&D Priorities, But Regulations May Hamper Foreign Industry Support

SHANGHAI - The Philippines government is formulating research priorities for the next five years, including health and biotechnology projects, to boost the country's research and development capabilities. But some industry observers warn that the country's desire to maintain drug prices through the use of steep price cuts will discourage foreign companies from participating in the country's life sciences development

Singapore, UK Award Infectious Disease Research Grants As Singapore Continues To Build Biomedical Research Base

SINGAPORE - Singapore and the United Kingdom have awarded SGD$4.5 million ($3.2 million) in grants covering six infectious disease research projects conducted jointly by Singapore and UK universities. The diseases include gastric flu, hepatitis B, dengue fever and tuberculosis

Latest Headlines
See All
UsernamePublicRestriction

Register

SC073615

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel